衰老与颞下颌关节骨关节病

doi:10.3969/j.issn.1005-4979.2013.05.001

摘要/Abstract

摘要： 骨关节病是导致中老年人慢性残疾最常见的原因之一，其病因和病理机制目前尚不明确。颞下颌关节骨关节病是一种能够累及整个颞下颌关节组织，导致患者口颌功能障碍及严重疼痛的慢性退行性疾病。近年来，衰老在骨关节病发生发展中的作用越来越受到重视。本文主要就衰老对颞下颌关节软骨细胞及软骨基质影响的研究进展做一概述，供研究参考。

关键词: 衰老； , 颞下颌关节； , 骨关节病； , 软骨细胞； , 软骨基质； , 衰老相关分泌表型

Abstract: Osteoarthritis (OA) is the most common cause of chronic disability in elder adults. The etiopathogenesis and pathomechanism of OA are still unclear. Temporomandibular joint (TMJ) OA is a degenerative disease involving all TMJ tissues and leads to functional deranged and severe pain. Recently, it was reported that aging is closely connected with the development and progression of OA. This lecture focused on potential mechanisms by which age-related changes in the chondrocytes and cartilage matrix of TMJ may contribute to the development and progression of OA.

Key words: aging, temporomandibular joint, osteoarthritis, chondrocyte, cartilage matrix, senescence-associated secretory phenotype

中图分类号:

R782.6

陈宁. 衰老与颞下颌关节骨关节病[J]. 《口腔颌面外科杂志》, 2013, 23(5): 325-329.

CHEN Ning. Aging and Temporomandibular Joint Osteoarthritis[J]. 《Journal of Oral and Maxillofacial Surgery》, 2013, 23(5): 325-329.

https://journal06.magtech.org.cn/Jweb_joms/CN/Y2013/V23/I5/325

参考文献

[1] Aigner T, Hemmel M, Neureiter D, et al. Apoptotic cell death is not a widespread phenomenon in normal aging and osteoarthritis human articular knee cartilage: a study of proliferation, programmed cell death (apoptosis), and viability of chondrocytes in normal and osteoarthritic human knee cartilage [J]. Arthritis Rheum, 2001,44(6): 1304-1312.

[2] Horton WE Jr, Feng L, Adams C. Chondrocyte apoptosis in development, aging and disease [J]. Matrix Biol, 1998,17(2): 107-115.

[3] Kühn K, D’Lima DD, Hashimoto S, et al. Cell death in cartilage[J]. Osteoarthritis Cartilage, 2004,12(1): 1-16.

[4] Aigner T, Kim HA, Roach HI. Apoptosis in osteoarthritis[J]. Rheum Dis Clin North Am, 2004,30(3): 639-653.

[5] Vignon E, Arlot M, Patricot LM, et al. The cell density of human femoral head cartilage [J]. Clin Orthop Relat Res, 1976,(121): 303-308.

[6] Taniguchi N, Caramés B, Ronfani L, et al. Aging-related loss of the chromatin protein HMGB2 in articular cartilage is linked to reduced cellularity and osteoarthritis [J]. Proc Natl Acad Sci U S A, 2009,106(4): 1181-1186.

[7] Martin JA, Buckwalter JA. Telomere erosion and senescence in human articular cartilage chondrocytes [J]. J Gerontol A Biol Sci Med Sci, 2001,56(4): B172-B179.

[8] Hayflick L. Intracellular determinants of cell aging [J]. Mech Ageing Dev, 1984,28(2-3): 177-185.

[9] Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors [J]. Cell, 2005,120(4): 513-522.

[10] Itahana K, Campisi J, Dimri GP. Mechanisms of cellular senescence in human and mouse cells [J]. Biogerontology, 2004,5(1): 1-10.

[11] Dai SM, Shan ZZ, Nakamura H, et al. Catabolic stress induces features of chondrocyte senescence through overexpression of caveolin 1: possible involvement of caveolin 1-induced down-regulation of articular chondrocytes in the pathogenesis of osteoarthritis [J]. Arthritis Rheum, 2006,54(3): 818-831.

[12] Freund A, Patil CK, Campisi J. p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype [J]. EMBO J, 2011,30(8): 1536-1548.

[13] Coppé JP, Patil CK, Rodier F, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor [J]. PLoS Biol, 2008,6(12): 2853-2868.

[14] Coppé JP, Desprez PY, Krtolica A, et al. The senescence-associated secretory phenotype: the dark side of tumor suppression [J]. Annu Rev Pathol, 2010,5: 99-118.

[15] Coppé JP, Rodier F, Patil CK, et al. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype [J]. J Biol Chem, 2011,286(42): 36396-36403.

[16] Rodier F, Coppé JP, Patil CK, et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion [J]. Nat Cell Biol, 2009,11(8): 973-979.

[17] Shen M, Luo Y, Niu Y, et al. 1,25(OH)2D deficiency induces temporomandibular joint osteoarthritis via secretion of senescence-associated inflammatory cytokines [J]. Bone, 2013, 55(2): 400-409.

[18] Mizushima N, Levine B, Cuervo AM, et al. Autophagy fights disease through cellular self-digestion [J]. Nature, 2008,451(7182): 1069-1075.

[19] Tooze SA, Yoshimori T. The origin of the autophagosomal membrane [J]. Nat Cell Biol, 2010,12(9): 831-835.

[20] Gamerdinger M, Hajieva P, Kaya AM, et al. Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3 [J]. EMBO J, 2009,28(7): 889-901.

[21] Haigis MC, Yankner BA. The aging stress response [J]. Mol Cell, 2010,40(2): 333-344.

[22] Caramés B, Hasegawa A, Taniguchi N, et al. Autophagy activation by rapamycin reduces severity of experimental osteoarthritis [J]. Ann Rheum Dis, 2012,71(4): 575-581.

[23] Lotz MK, Caramés B. Autophagy and cartilage homeostasis mechanisms in joint health, aging and OA [J]. Nat Rev Rheumatol, 2011,7(10): 579-587.

[24] Lotz M, Caramés B. Autophagy: a new therapeutic target in cartilage injury and osteoarthritis [J]. J Am Acad Orthop Surg, 2012,20(4): 261-262.

[25] Caramés B, Taniguchi N, Otsuki S, et al. Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis [J]. Arthritis Rheum, 2010,62(3): 791-801.

[26] Sasaki H, Takayama K, Matsushita T, et al. Autophagy modulates osteoarthritis-related gene expression in human chondrocytes [J]. Arthritis Rheum, 2012,64(6): 1920-1928.

[27] Caramés B, Taniguchi N, Seino D, et al. Mechanical injury suppresses autophagy regulators and pharmacologic activation of autophagy results in chondroprotection [J]. Arthritis Rheum, 2012,64(4): 1182-1192.

[28] Fukui N, Ikeda Y, Ohnuki T, et al. Regional differences in chondrocyte metabolism in osteoarthritis: a detailed analysis by laser capture microdissection [J]. Arthritis Rheum, 2008,58(1): 154-163.

[29] Sandell LJ, Aigner T. Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis [J]. Arthritis Res, 2001,3(2): 107-113.

[30] Aigner T, Zhu Y, Chansky HH, et al. Reexpression of type IIA procollagen by adult articular chondrocytes in osteoarthritic cartilage [J]. Arthritis Rheum, 1999,42(7): 1443-1450.

[31] Visco DM, Johnstone B, Hill MA, et al. Immunohistochemical analysis of 3-B-(-) and 7-D-4 epitope expression in canine osteoarthritis [J]. Arthritis Rheum, 1993,36(12): 1718-1725.

[32] Hudelmaier M, Glaser C, Hohe J, et al. Age-related changes in the morphology and deformational behavior of knee joint cartilage [J]. Arthritis Rheum, 2001,44(11): 2556-2561.

[33] Ding C, Cicuttini F, Scott F, et al. Association between age and knee structural change: a cross sectional MRI based study [J]. Ann Rheum Dis, 2005,64(4): 549-555.

[34] Verzijl N, Bank RA, TeKoppele JM, et al. AGEing and osteoarthritis: a different perspective [J]. Curr Opin Rheumatol, 2003,15(5): 616-622.

[35] Garg S, Syngle A, Vohra K. Efficacy and tolerability of advanced glycation end-products inhibitor in osteoarthritis: a randomized, double-blind, placebo-controlled study [J]. Clin J Pain, 2013,29(8):717-724.

[36] Yamabe S, Hirose J, Uehara Y, et al. Intracellular accumulation of advanced glycation end products induces apoptosis via endoplasmic reticulum stress in chondrocytes [J]. FEBS J, 2013,280(7):1617-1629.

[37] Chen AC, Temple MM, Ng DM, et al. Induction of advanced glycation end products and alterations of the tensile properties of articular cartilage [J]. Arthritis Rheum, 2002,46(12): 3212-3217.

[38] Verzijl N, DeGroot J, Ben ZC, et al. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis [J]. Arthritis Rheum, 2002,46(1): 114-123.

[39] Vos PA, DeGroot J, Barten-van Rijbroek AD, et al. Elevation of cartilage AGEs does not accelerate initiation of canine experimental osteoarthritis upon mild surgical damage [J]. J Orthop Res, 2012,30(9): 1398-1404.

[40] Goodwin W, McCabe D, Sauter E, et al. Rotenone prevents impact-induced chondrocyte death [J]. J Orthop Res, 2010,28(8): 1057-1063.

[41] Liu JT, Guo X, Ma WJ, et al. Mitochondrial function is altered in articular chondrocytes of an endemic osteoarthritis, Kashin-Beck disease [J]. Osteoarthritis Cartilage, 2010,18(9): 1218-1226.

[42] Scott JL, Gabrielides C, Davidson RK, et al. Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease [J]. Ann Rheum Dis, 2010,69(8): 1502-1510.

[43] Naik E, Dixit VM. Mitochondrial reactive oxygen species drive proinflammatory cytokine production [J]. J Exp Med, 2011,208(3): 417-420.

[44] Jallali N, Ridha H, Thrasivoulou C, et al. Vulnerability to ROS-induced cell death in ageing articular cartilage: the role of antioxidant enzyme activity [J]. Osteoarthritis Cartilage, 2005,13(7): 614-622.

[45] Aigner T, Fundel K, Saas J, et al. Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis [J]. Arthritis Rheum, 2006,54(11): 3533-3544.

选择文件类型/文献管理软件名称

选择包含的内容